FSD Pharma Inc (Sub Voting) (QNTM) EBITDA (2016 - 2026)
FSD Pharma Inc (Sub Voting) (QNTM) EBITDA from Mar 31, 2016 to Mar 31, 2026. The TTM FSD Pharma Inc (Sub Voting) (QNTM) EBITDA is -$20M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
FSD Pharma Inc (Sub Voting) (QNTM) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -1.93% |
| 3 Years TTM | -8.73% |
| 5 Years TTM | -7.54% |
| 10 Years TTM | +114.14% |
| All Time TTM | +133.07% |
Annual EBITDA change of FSD Pharma Inc (Sub Voting) (QNTM)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$2.74M | -89.38% |
| 2025 | -$26M | +79.35% |
| 2024 | -$14M | -8.52% |
| 2023 | -$16M | -28.93% |
| 2022 | -$22M | -25.82% |
| 2021 | -$30M | +22.62% |
| 2020 | -$24M | -23.95% |
| 2019 | -$32M | +93.35% |
| 2018 | -$17M | +490.71% |
| 2017 | -$2.80M | +9233.33% |
| 2016 | -$30K | N/A |
| 2015 | -$30K | N/A |
Comparison FSD Pharma Inc (Sub Voting) (QNTM) five years EBITDA CAGR with competitors
FSD Pharma Inc (Sub Voting) (QNTM) five years EBITDA CAGR is -7.54%.